March 19, 2019
NapaJen Pharma, a California-based biotech specializing in immune-cell targeted drug delivery system (DDS) technologies, said on March 18 that it has forged a research collaboration with Astellas Pharma for the discovery and development of novel oligonucleotide therapeutic candidates. Under the...read more